Author Archives: Lu Rahman

Evaluation of checkpoint inhibitor therapies using an MLR assay: webinar

Immune checkpoints are signalling molecules that control the synapse between T cells and antigen presenting cells (APCs). Checkpoint inhibitor therapies target and inhibit the signals that ‘switch off’ T cells, leading to an upregulation of T cell activation and tumour cell killing. The mixed lymphocyte reaction (MLR) mimics the T… Read More

#News

Evaluation of checkpoint inhibitor therapies using an MLR assay

Immune checkpoints are signalling molecules that control the synapse between T cells and antigen presenting cells (APCs). Checkpoint inhibitor therapies target and inhibit the signals that ‘switch off’ T cells, leading to an upregulation of T cell activation and tumour cell killing.  The mixed lymphocyte reaction (MLR) mimics the T… Read More

Webinar date:
Brought to you by Sartorius
#Webinars

#CRISPR #Drug discovery #Liquid handling #Synthetic biology

Expert advice: maintaining lab flow throughout the pandemic

Lu Rahman talks to John Fuller, Product Manager–Drug Discovery, Beckman Coulter Life Sciences about the pandemic’s impact on this global organisation and its customers — and what to expect in 2021 and beyond. Not surprisingly, the emergence of the Covid-19 pandemic in 2020 caused hundreds, if not thousands of… Read More

#Exclusive Content #News #Opinion

#Drug discovery #High throughput screening #Whitepaper

Improve the drug discovery tool box

Making good decisions in the drug discovery process requires software to effectively manage the size and complexity of multiparametric datasets. Companies that most quickly and accurately identify key drug discovery parameters will win the race to identify the most appropriate targets and develop medicines to affect them. PerkinElmer has produced… Read More

#News

White paper: Improve the drug discovery tool box

Making good decisions in the drug discovery process requires software to effectively manage the size and complexity of multiparametric datasets. Companies that most quickly and accurately identify key drug discovery parameters will win the race to identify the most appropriate targets and develop medicines to affect them.

#Intelligence #Resources

Automation that connects your drug discovery workflow

Scientific and technological advancements continue to emphasise the importance of automation, both in the physical and digital world. Given recent discussions about the lab of the future, the benefits have expanded to highlight how automation can support greater connectivity between data and workflows, paving the way to a ‘smarter lab’. Read More

#Intelligence #Resources

#Metabolomics #Precision medicine

The advent of metabolic precision medicine

Kirk Pappan, Translational Science Team Lead and Jonathan Kitley, Scientific Content Creator at Owlstone Medical explain why genes are just part of the precision medicine journey. To date, most research around precision medicine has focused on what can be achieved through genetics and genomics. That makes logical sense as a… Read More

#Exclusive Content #News

#Biomarkers #Lipids #Mass spectrometry / NMR #Neurodegenerative disorders #SLIM-based High-Resolution Ion Mobility (HRIM)

Enabling advancements in research of biomarkers

Kim Ekroos PhD, Founder & CEO Lipidomics Consulting and Kelly Moser PhD, Lab Operations Manager and Applications Scientist, MOBILion Systems examine advancements in research of biomarkers for early diagnostics and effective treatments for neurodegenerative disorders with High-Resolution Ion Mobility Mass Spectrometry Although the first descriptions and classifications of lipids appeared… Read More

#Exclusive Content

#Antibodies #Covid-19 #Online focus

Putting function first to find antibodies against difficult target

Three case studies from Berkeley Lights The Covid-19 pandemic has illuminated how a coordinated response to infectious diseases can result in the development and commercialisation of novel vaccines and therapies at record pace. Berkeley Lights has established multiple partnerships worldwide to provide access to its platform to rapidly accelerate the… Read More

#Covid-19 #News

#Cell and protein analysis #Covid-19 #Immunology / Virology & Vaccines #Podcast

Advances in cell and protein analysis for virology research – podcast

This exclusive podcast features Dr Hongshan Li, Applications Manager, Sartorius, discussing advances in cell and protein analysis for virology research. This episode examines virology research – what’s currently happening in the sector and how new advances in technology are helping push forward innovation and drug development. With COVID-19 playing such… Read More

#Covid-19 #Editor's Choice #News

Your guide to fragment-based drug discovery

Fragment-based drug discovery (FBDD) is one of the most popular approaches for finding lead compounds and it is becoming more widely adopted by pharma companies. FBDD is the solution researchers turn to when faced with challenging targets that call for compound libraries that offer more diverse molecules — especially from… Read More

#DDW eBooks

Maximize your productivity with high-throughput flow cytometry automation

High-throughput flow cytometry technologies have revolutionized drug screening, says Bio-Rad. This application note explains how you can take throughput and reproducibility to the next level using the ZE5 Cell Analyzer. In the current environment, with increased pressures on drug companies, Bio-Rad believes using effective automation is critical. Featured in this… Read More

#Resources

#Assays #Automation / robotics #Flow Cytometry

How to boost productivity with high-throughput flow cytometry automation

High-throughput flow cytometry technologies have revolutionised drug screening, says Bio-Rad. This application note explains how you can take throughput and reproducibility to the next level using the ZE5 Cell Analyzer. In the current environment, with increased pressures on drug companies, Bio-Rad believes using effective automation is critical. This application note… Read More

#News

#Compounds #Drug discovery #Pharmaceuticals

A guide to fragment-based drug discovery

Fragment-based drug discovery (FBDD) is one of the most popular approaches for finding lead compounds and it is becoming more widely adopted by pharma companies. FBDD is the solution researchers turn to when faced with challenging targets that call for compound libraries that offer more diverse molecules — especially from… Read More

#News

#Covid-19 #Immunology / Virology & Vaccines

Professor Sarah Gilbert wins award for her work on the Oxford vaccine

The lead researcher on the Oxford vaccine team, Professor Gilbert is Professor of Vaccinology in the Nuffield Department of Medicine at the University of Oxford. She is the Oxford Project Leader for ChAdOx1 nCoV-19, a vaccine against the novel coronavirus, SARSCoV-2, with approval for use in many countries around the… Read More

#Covid-19 #Editor's Choice #News #Trending News